Float Short %

27.57

Margin Of Safety %

Put/Call OI Ratio

0.12

EPS Next Q Diff

0.15

EPS Last/This Y

0.5

EPS This/Next Y

0.45

Price

1.79

Target Price

12.2

Analyst Recom

1.69

Performance Q

-66.16

Relative Volume

2.11

Beta

0.93

Ticker: IOVA

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-04-14	IOVA	3.41	0.16	0.01	138139
2025-04-15	IOVA	3.22	0.16	0.13	141837
2025-04-16	IOVA	3.07	0.16	0.88	142777
2025-04-17	IOVA	3.07	0.15	0.07	142574
2025-04-18	IOVA	3.06	0.15	0.05	142574
2025-04-21	IOVA	3.08	0.15	0.13	141370
2025-04-22	IOVA	3.21	0.15	0.91	143181
2025-04-23	IOVA	3.19	0.16	0.22	145036
2025-04-24	IOVA	3.37	0.16	0.20	146132
2025-04-25	IOVA	3.51	0.15815549378936	0.1787913340935	147505
2025-04-28	IOVA	3.61	0.16199019334525	0.51018161805173	141714
2025-04-29	IOVA	3.57	0.17	0.15	145468
2025-04-30	IOVA	3.58	0.17	0.08	147472
2025-05-01	IOVA	3.33	0.17	0.39	147538
2025-05-02	IOVA	3.5	0.17	0.02	148869
2025-05-05	IOVA	3.49	0.17	0.54	147208
2025-05-06	IOVA	3.09	0.17	0.62	149441
2025-05-07	IOVA	3.13	0.17	0.07	151875
2025-05-08	IOVA	3.05	0.17	1.95	154892
2025-05-09	IOVA	1.75	0.20	0.21	162501
2025-05-12	IOVA	1.92	0.12	0.16	160028
2025-05-13	IOVA	1.785	0.12	0.10	165078
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-04-14	IOVA	3.41	43.8	50.1	-0.78
2025-04-15	IOVA	3.23	43.3	87.3	-0.78
2025-04-16	IOVA	3.07	43.7	86.9	-0.78
2025-04-17	IOVA	3.06	43.7	66.0	-0.78
2025-04-18	IOVA	3.06	43.7	64.5	-0.78
2025-04-21	IOVA	3.07	43.7	63.0	-0.78
2025-04-22	IOVA	3.21	43.7	45.8	-0.78
2025-04-23	IOVA	3.19	43.7	67.3	-0.78
2025-04-24	IOVA	3.37	43.7	39.7	-0.78
2025-04-25	IOVA	3.51	43.7	45.2	-0.78
2025-04-28	IOVA	3.61	43.7	52.4	-0.78
2025-04-29	IOVA	3.56	43.7	70.5	-0.78
2025-04-30	IOVA	3.59	43.7	68.7	-0.78
2025-05-01	IOVA	3.33	43.7	94.2	-0.78
2025-05-02	IOVA	3.50	43.7	42.2	-0.78
2025-05-05	IOVA	3.49	43.7	65.9	-0.78
2025-05-06	IOVA	3.09	43.7	114.7	-0.78
2025-05-07	IOVA	3.13	43.7	60.1	-0.78
2025-05-08	IOVA	3.16	43.7	60.2	-0.78
2025-05-09	IOVA	1.75	45.2	262.9	-0.78
2025-05-12	IOVA	1.93	45.2	19.2	-0.78
2025-05-13	IOVA	1.79	45.2	113.2	-0.78
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-04-14	IOVA	-0.08	3.84	28.31
2025-04-15	IOVA	-0.08	3.84	28.31
2025-04-16	IOVA	-0.08	3.84	28.31
2025-04-17	IOVA	-0.08	3.84	28.31
2025-04-18	IOVA	-0.08	3.84	28.31
2025-04-21	IOVA	-0.08	2.01	28.31
2025-04-22	IOVA	-0.08	2.01	28.31
2025-04-23	IOVA	-0.08	2.01	28.31
2025-04-24	IOVA	-0.08	2.01	28.31
2025-04-25	IOVA	-0.08	2.01	28.31
2025-04-28	IOVA	-0.08	2.02	26.88
2025-04-29	IOVA	-0.08	2.02	26.88
2025-04-30	IOVA	-0.08	2.02	26.88
2025-05-01	IOVA	-0.08	2.02	26.88
2025-05-02	IOVA	-0.08	2.02	26.88
2025-05-05	IOVA	-0.08	2.69	26.39
2025-05-06	IOVA	-0.08	2.69	26.39
2025-05-07	IOVA	-0.08	2.69	26.39
2025-05-08	IOVA	-0.08	2.69	26.39
2025-05-09	IOVA	-0.08	2.69	26.39
2025-05-12	IOVA	-0.08	1.43	27.57
2025-05-13	IOVA	-0.08	1.43	27.57
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-0.36

Avg. EPS Est. Current Quarter

-0.24

Avg. EPS Est. Next Quarter

-0.21

Insider Transactions

-0.08

Institutional Transactions

1.43

Beta

0.93

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

102

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

96.7

Max Drawdown 5-Year %

-96.7

Target Price

12.2

P/E

Forward P/E

PEG

P/S

2.81

P/B

0.78

P/Free Cash Flow

EPS

-1.23

Average EPS Est. Cur. Y

-0.78

EPS Next Y. (Est.)

-0.33

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-176.49

Relative Volume

2.11

Return on Equity vs Sector %

-72.6

Return on Equity vs Industry %

-55.6

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

113.2

Iovance Biotherapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 838

Iovance Biotherapeutics, Inc., a commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States. The company offers Amtagvi, a tumor-derived autologous T cell immunotherapy used to treat adult patients with unresectable or metastatic melanoma; and Proleukin, an interleukin-2 product for the treatment of patients with metastatic melanoma and metastatic renal cell carcinoma. It develops lifileucel for treatment of melanoma, cervical cancer, non-small cell lung cancer (NSCLC), endometrial cancer, and head and neck squamous cell carcinoma; IOV-2001 to treat chronic lymphocytic leukemia and small lymphocytic lymphoma; IOV-4001 for the treatment of melanoma and NSCLC; and IOV-3001, an antibody cytokine engrafted protein for use in the TIL therapy treatment regimen. The company has collaborations and licensing agreements with WuXi Advanced Therapies, Inc.; National Institutes of Health; the National Cancer Institute; H. Lee Moffitt Cancer Center; The University of Texas M.D. Anderson Cancer Center; Cellectis S.A.; Novartis Pharma AG; and Boehringer Ingelheim Biopharmaceuticals GmbH. The company was formerly known as Lion Biotechnologies, Inc. and changed its name to Iovance Biotherapeutics, Inc. in June 2017. Iovance Biotherapeutics, Inc. was incorporated in 2007 and is headquartered in San Carlos, California.

stock quote shares IOVA – Iovance Biotherapeutics, Inc. Stock Price stock today

news today IOVA – Iovance Biotherapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch IOVA – Iovance Biotherapeutics, Inc. yahoo finance google finance

stock history IOVA – Iovance Biotherapeutics, Inc. invest stock market

stock prices IOVA premarket after hours

ticker IOVA fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: IOVA

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y